Kura Oncology Inc (NAS:KURA)
$ 8.86 -0.08 (-0.89%) Market Cap: 688.99 Mil Enterprise Value: 250.32 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 29/100

Kura Oncology Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2022 / 03:15PM GMT
Release Date Price: $15.09 (+2.72%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

There we go. So I just wanted to thank everybody for attending fireside chat with Kura, attending a conference in Miami. So very grateful everyone came down, and I hope everyone is feeling, feeling great. And hopefully, their meetings are going well. And my name is Peter Lawson. I'm hosting this fireside chat with Kura. So I am one of biotech analysts here. I just want to thank Troy Wilson, CEO from Kura, for coming down and support as well and been in person for our conference. So it's really exciting after 2 years has been at home and back in person again, thankfully.

Questions & Answers

Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

So first question, I guess, kind of the differentiation of Kura in the oncology space or maybe you want to cover kind of a company overview and just a few seconds on that.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot